Carregant...

Dominant-Negative Androgen Receptor Inhibition of Intracrine Androgen-Dependent Growth of Castration-Recurrent Prostate Cancer

BACKGROUND: Prostate cancer (CaP) is the second leading cause of cancer death in American men. Androgen deprivation therapy is initially effective in CaP treatment, but CaP recurs despite castrate levels of circulating androgen. Continued expression of the androgen receptor (AR) and its ligands has...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Titus, Mark A., Zeithaml, Brian, Kantor, Boris, Li, Xiangping, Haack, Karin, Moore, Dominic T., Wilson, Elizabeth M., Mohler, James L., Kafri, Tal
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3260230/
https://ncbi.nlm.nih.gov/pubmed/22272301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0030192
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!